IMMUNOPRIN 75 MG õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

immunoprin 75 mg õhukese polümeerikattega tablett

sandoz pharmaceuticals d.d. - asatiopriin - õhukese polümeerikattega tablett - 75mg 50tk

IMMUNOPRIN 100 MG õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

immunoprin 100 mg õhukese polümeerikattega tablett

sandoz pharmaceuticals d.d. - asatiopriin - õhukese polümeerikattega tablett - 100mg 100tk; 100mg 50tk

Jayempi Euroopa Liit - eesti - EMA (European Medicines Agency)

jayempi

nova laboratories ireland limited - azathioprine - transplantaadi tagasilükkamine - immunosupressandid - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.

Ibrance Euroopa Liit - eesti - EMA (European Medicines Agency)

ibrance

pfizer europe ma eeig  - palbociclib - rinnanäärmed - antineoplastilised ained - ibrance on näidustatud ravi hormooni retseptori (hr) positiivne, inimese epidermaalse kasvufaktori retseptor 2 (her2) negatiivne lokaalselt kaugelearenenud või metastaatilise rinnavähi:kombinatsioonis aromataasi inhibiitor;koos fulvestrant naistel, kes on saanud enne endokriinse ravi. pre - või perimenopausal naised, endokriinse ravi tuleks koos luteiniseeriva hormooni vabastav hormoon (lhrh) agonist.

Solymbic Euroopa Liit - eesti - EMA (European Medicines Agency)

solymbic

amgen europe b.v. - adalimumab - arthritis, psoriatic; spondylitis, ankylosing; crohn disease; colitis, ulcerative; hidradenitis suppurativa; psoriasis; arthritis, rheumatoid - immunosupressandid - palun vaadake jaotist 4. tooteteabe omaduste kokkuvõtte 1. osa tooteinfo dokumendis.

Cyltezo Euroopa Liit - eesti - EMA (European Medicines Agency)

cyltezo

boehringer ingelheim international gmbh - adalimumab - hidradenitis suppurativa; arthritis, psoriatic; psoriasis; crohn disease; arthritis, juvenile rheumatoid; uveitis; arthritis, rheumatoid; colitis, ulcerative; spondylitis, ankylosing - immunosupressandid - palun vaadake jaotist 4. tooteteabe omaduste kokkuvõtte 1. osa tooteinfo dokumendis.

LANVIS tablett Eesti - eesti - Ravimiamet

lanvis tablett

aspen pharma trading limited - tioguaniin - tablett - 40mg 25tk

ATSIMUTIN õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

atsimutin õhukese polümeerikattega tablett

bausch health ireland limited - asatiopriin - õhukese polümeerikattega tablett - 50mg 30tk; 50mg 50tk; 50mg 28tk; 50mg 100tk; 50mg 56tk

ATSIMUTIN õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

atsimutin õhukese polümeerikattega tablett

bausch health ireland limited - asatiopriin - õhukese polümeerikattega tablett - 25mg 90tk; 25mg 28tk; 25mg 100tk; 25mg 50tk; 25mg 56tk

METHOTREXATE ORION tablett Eesti - eesti - Ravimiamet

methotrexate orion tablett

orion corporation - metotreksaat - tablett - 2,5mg 100tk